Cargando…
Statins attenuate cholesterol-induced ROS via inhibiting NOX2/NOX4 and mitochondrial pathway in collecting ducts of the kidney
BACKGROUND: Statins therapy has been primarily recommended for the prevention of cardiovascular risk in patients with chronic kidney diseases. Statins has also been proved some benefits in lipid-induced kidney diseases. The current study aims to investigate the protection and underlying mechanisms o...
Autores principales: | Wang, Ani, Lin, Yu, Liang, Baien, Zhao, Xiaoduo, Qiu, Miaojuan, Huang, Hui, Li, Chunling, Wang, Weidong, Kong, Yonglun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102638/ https://www.ncbi.nlm.nih.gov/pubmed/35562673 http://dx.doi.org/10.1186/s12882-022-02815-6 |
Ejemplares similares
-
Tubular Mas receptor mediates lipid-induced kidney injury
por: Kong, Yonglun, et al.
Publicado: (2021) -
Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells
por: Qiu, Miaojuan, et al.
Publicado: (2018) -
NOX- and ROS-Driven Hypertension in Elastin Insufficiency
por: Gavazzi, Gaëtan, et al.
Publicado: (2021) -
NOX-like ROS production by glutathione reductase
por: Diaz, Julia M., et al.
Publicado: (2022) -
NOX Dependent ROS Generation and Cell Metabolism
por: Pecchillo Cimmino, Tiziana, et al.
Publicado: (2023)